BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31558785)

  • 1. Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions.
    Wu NY; Fang C; Huang HS; Wang J; Chu TY
    Mod Pathol; 2020 Jan; 33(1):29-37. PubMed ID: 31558785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects.
    Chu TY; Khine AA; Wu NY; Chen PC; Chu SC; Lee MH; Huang HS
    Mol Carcinog; 2023 Sep; 62(9):1417-1427. PubMed ID: 37265438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
    Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
    J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells.
    Wu NY; Huang HS; Chao TH; Chou HM; Fang C; Qin CZ; Lin CY; Chu TY; Zhou HH
    Cell Rep; 2017 Mar; 18(11):2557-2565. PubMed ID: 28297660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
    Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
    Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
    Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
    Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants.
    Ronchi S; Facchi S; Di Lauro E; Libera L; Carnevali IW; Zefiro F; Alexandrova E; Rizzo F; Sessa F; Tibiletti MG
    Pathol Res Pract; 2024 Mar; 255():155183. PubMed ID: 38364651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.
    Munakata S; Yamamoto T
    Int J Gynecol Pathol; 2015 Jan; 34(1):9-18. PubMed ID: 25473747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.
    Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ
    Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation.
    Hsu CF; Huang HS; Chen PC; Ding DC; Chu TY
    EBioMedicine; 2019 Mar; 41():597-609. PubMed ID: 30852161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.
    Lin SF; Gerry E; Shih IM
    J Pathol; 2017 May; 242(1):3-6. PubMed ID: 28054715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis.
    Mei J; Tian H; Huang HS; Hsu CF; Liou Y; Wu N; Zhang W; Chu TY
    Cell Prolif; 2021 May; 54(5):e13029. PubMed ID: 33768671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria].
    Lax S
    Pathologe; 2009 Dec; 30 Suppl 2():210-6. PubMed ID: 19859709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.
    Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A
    Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
    Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
    J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.